Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:39248018

Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer.

Elizabeth T Evans · Emily F Page · Alex Seok Choi · Zainab Shonibare · Andrea G Kahn · Rebecca C Arend · Karthikeyan Mythreye

Cancer medicine · 2024 doi:10.1002/cam4.7368

Paper

complete

Experiment

partial

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:39248018
kind
science-record
content_hash
sha256:a5a3e3acb993c517c9b24b1667069fc921b3290b3d70521274e002ede0b19e8f
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T20:29:23Z
updated_at
2026-11-01T22:55:07Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer.
doi
10.1002/cam4.7368
pmid
39248018
authors array · 7 items
[0]
Elizabeth T Evans
[1]
Emily F Page
[2]
Alex Seok Choi
[3]
Zainab Shonibare
[4]
Andrea G Kahn
[5]
Rebecca C Arend
[6]
Karthikeyan Mythreye
journal
Cancer medicine
year
2024
abstract
OBJECTIVE: The TGF-β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin-βA and INHBB/ Inhibin-βB) between malignant and ovarian tissues at the RNA and protein level and assess the relationship between activin and immune cells in EOC. METHODS: Publicly available RNA sequencing data were accessed from GEO (#GSE143897) with normalization and quantification performed via DESeq2. Immune gene expression profile was further explored within the TCGA-OV cohort derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A and T-cell markers CD8 and FoxP3 at the protein level. ELISA to activin-A was used to assess levels in the ascites of advanced EOC patients. Kaplan-Meier curves were generated to visualize survival outcomes. RESULTS: Gene expression levels of components of the activin signaling pathway were elevated within EOC when compared to a benign cohort, with differences in activin type I/II receptor gene profiles identified. Additionally, INHBA gene expression was linked to lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of CD8 and FOXP3 staining with activin A at the protein level in both primary and metastatic epithelial ovarian cancer samples. Furthermore, Activin-A (inhibin-βA) is significantly elevated in EOC patient ascites. CONCLUSION: INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration. Our findings suggest that activin-A may play a role in suppressing anti-tumor immunity in EOC, highlighting its potential as a therapeutic target.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3). Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl). Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR). Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated. We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D). However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C).
kind
methodological
target
null
evidence array · 6 items
[0] object · 3 fields
asset
source:pmid:39248018
locator
sections[4] "Bioinformatics" paragraph 2
quote
Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3).
[1] object · 3 fields
asset
source:pmid:39248018
locator
sections[5] "Survival analysis" paragraph 2
quote
Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl).
[2] object · 3 fields
asset
source:pmid:39248018
locator
sections[5] "Survival analysis" paragraph 2
quote
Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR).
[3] object · 3 fields
asset
source:pmid:39248018
locator
sections[8] "Statistical analysis" paragraph 2
quote
Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated.
[4] object · 3 fields
asset
source:pmid:39248018
locator
sections[11] "A lymphocytic gene profile was positively correlated with activin A expression" paragraph 2
quote
We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D).
[5] object · 3 fields
asset
source:pmid:39248018
locator
sections[13] "Activin‐A is elevated in EOC patient ascites" paragraph 2
quote
However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C).
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The data that support the findings of this study are all in the manuscript and also available upon request from the corresponding author.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39248018
locator
sections[23] "DATA AVAILABILITY STATEMENT" paragraph 2
quote
The data that support the findings of this study are all in the manuscript and also available upon request from the corresponding author.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39248018
locator
sections[0] "Abstract" paragraph 4
quote
INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:39248018
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 1 item
[0] object · 15 fields
id
source:pmid:39248018
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1002/cam4.7368
sha256
sha256:2a770173006ef64f60c63cf93089d9ec0756e0418928e834ae972a5978b68f5a
bytes
43967
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1002/cam4.7368
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC11381957
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
gaps array · 0 items
analysis object · 4 fields
state
complete
methods array · 5 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
anova
label
Group comparison
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
reordered
quote
Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3). Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl). Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR). Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated. We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D). However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C).
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
differential_expression
specific
deseq2
label
Differential expression analysis
dsl_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
count_matrix_with_condition
evidence object · 3 fields
score
0.7
band
medium
quote
DESeq2
[3] object · 10 fields
id
method-4
family
correlation_analysis
specific
pearson
label
Correlation analysis
dsl_operations array · 1 item
[0]
pearson_r
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
paired_numeric_columns
evidence object · 3 fields
score
0.8
band
high
quote
Pearson's correlation
[4] object · 10 fields
id
method-5
family
diagnostic_evaluation
specific
roc
label
Diagnostic test evaluation
dsl_operations array · 6 items
[0]
confusion_counts
[1]
roc_curve
[2]
sensitivity_specificity
[3]
solve_confusion_matrix
[4]
classification_metrics
[5]
published_precision_envelope
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
reference_standard_and_test
evidence object · 3 fields
score
0.8
band
high
quote
ROC curve
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 1 item
[0]
#GSE143897
resolved_accessions array · 0 items
statements array · 1 item
[0]
The data that support the findings of this study are all in the manuscript and also available upon request from the corresponding author.
basis
The paper names #GSE143897, but the accession does not resolve in the repository (no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
assets array · 1 item
[0]
source:pmid:39248018
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T19:30:43Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
12681
completion_tokens
2170
cached_tokens
256
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:39248018
type
paper
label
pmid:39248018
[1] object · 3 fields
id
source:pmid:39248018
type
manuscript
label
PMID 39248018 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:39248018
type
paper
label
pmid:39248018
[1] object · 3 fields
id
source:pmid:39248018
type
manuscript
label
PMID 39248018 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-39248018
type
extraction
used array · 1 item
[0]
source:pmid:39248018
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:39248018
parent_hash
sha256:cdce60dca16ce1fbeefd07b4e0b8f75ee85218ee83ce10f0c43d97207e17cb47
fork_of
null
gaps array · 5 items
[0]
execution.not_run
[1]
review.human_critique
[2]
review.independent_reader
[3]
review.machine_critique
[4]
step:obtain_source_data blocked on data:accession_absent
assays array · 3 items
[0] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A
[1]
o lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of
order_basis
paper_text_order:781
id
assay:1
[1] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 2 items
[0]
markers CD8 and FoxP3 at the protein level. ELISA to activin-A was used to assess levels in th
[1]
for malignancy. 21 , 25 We also performed an ELISA to detect activin‐A within the ascites of 24
order_basis
paper_text_order:902
id
assay:2
[2] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3). Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl). Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR). Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated. We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D). However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C).
order_basis
consumes_earlier_output
id
assay:3
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:39248018", "kind": "science-record", "revision": 4, "content_hash": "sha256:a5a3e3acb993c517c9b24b1667069fc921b3290b3d70521274e002ede0b19e8f", "created_at": "2026-11-01T20:29:23Z", "updated_at": "2026-11-01T22:55:07Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer.", "doi": "10.1002/cam4.7368", "pmid": "39248018", "authors": ["Elizabeth T Evans", "Emily F Page", "Alex Seok Choi", "Zainab Shonibare", "Andrea G Kahn", "Rebecca C Arend", "Karthikeyan Mythreye"], "journal": "Cancer medicine", "year": 2024, "abstract": "OBJECTIVE: The TGF-β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin-βA and INHBB/ Inhibin-βB) between malignant and ovarian tissues at the RNA and protein level and assess the relationship between activin and immune cells in EOC.\nMETHODS: Publicly available RNA sequencing data were accessed from GEO (#GSE143897) with normalization and quantification performed via DESeq2. Immune gene expression profile was further explored within the TCGA-OV cohort derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A and T-cell markers CD8 and FoxP3 at the protein level. ELISA to activin-A was used to assess levels in the ascites of advanced EOC patients. Kaplan-Meier curves were generated to visualize survival outcomes.\nRESULTS: Gene expression levels of components of the activin signaling pathway were elevated within EOC when compared to a benign cohort, with differences in activin type I/II receptor gene profiles identified. Additionally, INHBA gene expression was linked to lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of CD8 and FOXP3 staining with activin A at the protein level in both primary and metastatic epithelial ovarian cancer samples. Furthermore, Activin-A (inhibin-βA) is significantly elevated in EOC patient ascites.\nCONCLUSION: INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration. Our findings suggest that activin-A may play a role in suppressing anti-tumor immunity in EOC, highlighting its potential as a therapeutic target.", "claims": [{"id": "claim-method", "statement": "Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3). Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl). Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR). Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated. We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D). However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:39248018", "locator": "sections[4] \"Bioinformatics\" paragraph 2", "quote": "Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3)."}, {"asset": "source:pmid:39248018", "locator": "sections[5] \"Survival analysis\" paragraph 2", "quote": "Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl)."}, {"asset": "source:pmid:39248018", "locator": "sections[5] \"Survival analysis\" paragraph 2", "quote": "Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR)."}, {"asset": "source:pmid:39248018", "locator": "sections[8] \"Statistical analysis\" paragraph 2", "quote": "Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated."}, {"asset": "source:pmid:39248018", "locator": "sections[11] \"A lymphocytic gene profile was positively correlated with activin A expression\" paragraph 2", "quote": "We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D)."}, {"asset": "source:pmid:39248018", "locator": "sections[13] \"Activin‐A is elevated in EOC patient ascites\" paragraph 2", "quote": "However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The data that support the findings of this study are all in the manuscript and also available upon request from the corresponding author.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:39248018", "locator": "sections[23] \"DATA AVAILABILITY STATEMENT\" paragraph 2", "quote": "The data that support the findings of this study are all in the manuscript and also available upon request from the corresponding author."}], "state": "complete"}, {"id": "claim-target-result", "statement": "INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:39248018", "locator": "sections[0] \"Abstract\" paragraph 4", "quote": "INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "INHBA expression is elevated within EOC, correlating with worse survival, with activin protein levels correlating with specific immune infiltration.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:39248018"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:39248018", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1002/cam4.7368", "sha256": "sha256:2a770173006ef64f60c63cf93089d9ec0756e0418928e834ae972a5978b68f5a", "bytes": 43967, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1002/cam4.7368", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC11381957", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}], "gaps": []}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "reordered", "quote": "Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3). Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl). Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR). Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated. We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D). However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C)."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "differential_expression", "specific": "deseq2", "label": "Differential expression analysis", "dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["count_matrix_with_condition"], "evidence": {"score": 0.7, "band": "medium", "quote": "DESeq2"}}, {"id": "method-4", "family": "correlation_analysis", "specific": "pearson", "label": "Correlation analysis", "dsl_operations": ["pearson_r"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["paired_numeric_columns"], "evidence": {"score": 0.8, "band": "high", "quote": "Pearson's correlation"}}, {"id": "method-5", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.8, "band": "high", "quote": "ROC curve"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": ["#GSE143897"], "resolved_accessions": [], "statements": ["The data that support the findings of this study are all in the manuscript and also available upon request from the corresponding author."], "basis": "The paper names #GSE143897, but the accession does not resolve in the repository (no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "assets": ["source:pmid:39248018"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:30:43Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 12681, "completion_tokens": 2170, "cached_tokens": 256}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:39248018", "type": "paper", "label": "pmid:39248018"}, {"id": "source:pmid:39248018", "type": "manuscript", "label": "PMID 39248018 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:39248018", "type": "paper", "label": "pmid:39248018"}, {"id": "source:pmid:39248018", "type": "manuscript", "label": "PMID 39248018 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-39248018", "type": "extraction", "used": ["source:pmid:39248018"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:39248018", "parent_hash": "sha256:cdce60dca16ce1fbeefd07b4e0b8f75ee85218ee83ce10f0c43d97207e17cb47", "fork_of": null, "generation": 3}, "gaps": ["execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["derived from The Cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to evaluate activin A", "o lymphocytic immune markers in EOC samples. Immunohistochemistry analysis revealed a positive correlation of"], "order_basis": "paper_text_order:781", "id": "assay:1"}, {"role": "data_generation", "definition_id": "elisa", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["markers CD8 and FoxP3 at the protein level. ELISA to activin-A was used to assess levels in th", "for malignancy. 21 , 25 We also performed an ELISA to detect activin‐A within the ascites of 24"], "order_basis": "paper_text_order:902", "id": "assay:2"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Normalization and downstream analysis for gene quantification was performed with DESeq2 (version 1.38.3). Survival data were generated from the online database KM Plotter, using the Affymetrix Probe ID INHBA (204926_at) and INHBA (2105511_a_atl). Gene expression was split into high and low using the median expression, and log‐rank statistics were utilized to calculate both p‐value and hazard ratio (HR). Multiple comparisons were evaluated using one‐way ANOVA, with Tukey post‐hoc analysis of a significant ANOVA group effect then performed as indicated. We find that when comparing INHBA levels against the 16 immune population signatures, the most significant Pearson's correlation was seen with a Treg signature (Figure 2D). However, using Cox log‐rank hazards regression to analyze the influence of activin‐A levels in ascites on patient OS, we found that activin‐A level in ascites did not correlate strongly with survival outcomes (HR 0.95, 95% confidence interval 0.42–2.16) (Figure 4B,C)."], "order_basis": "consumes_earlier_output", "id": "assay:3"}]}